Xcout Intel
Alpha Tau Medical
Alpha Tau Medical is an Israeli medical technology company developing Alpha DaRT, a localized targeted alpha-radiation therapy for treating solid tumors. Its technology is intended for cancer patients and is administered by healthcare providers such as oncologists and hospitals.
Subscribe to see Alpha Tau Medical’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Alpha Tau Medical at a glance
Alpha Tau Medical is a medical devices company headquartered in Jerusalem, Israel, founded in 2015. Xcout tracks 16 named people at Alpha Tau Medical, including Uzi Sofer (Chief Executive Officer & Chairman). Xcout recorded 2 job postings from Alpha Tau Medical in the last 90 days.
Alpha Tau Medical leadership
- Uzi SoferChief Executive Officer & Chairman
- Raphi LevyChief Financial Officer
- Ronen SegalChief Technology Officer
- Robert DenChief Medical Officer & Member of Scientific Advisory Board
- Amnon GatChief Operations Officer
- Yona KeisariChief Scientific Officer
10 more named people on record for Alpha Tau Medical, with roles, board committees and tenure — see the full roster →
Alpha Tau Medical funding rounds before its IPO
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $29M | 1 named |
Financing after the IPO — public offerings and SEC Form D private placements — is not listed as a funding round.
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Alpha Tau Medical
Xcout recorded 2 job postings from Alpha Tau Medical in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Alpha Tau Medical's hiring signals →
Investors
Alpha Tau Medical competitors
A few of Alpha Tau Medical's closest competitors — see the full list of competitors and alternatives →
SpectraCure is a medical technology company that develops a precision treatment system for localized prostate cancer and other internal solid tumors. The company utilizes photodynamic therapy (PDT) combined with a proprietary dose-planning platform to offer targeted, minimally invasive treatments for prostate cancer patients.
Eckert & Ziegler SE manufactures and sells isotope technology components in Europe, North America, Asia, and internationally. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds based on iodine-125; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of choroidal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, consumables, therapeutic products and plant engineering, and other services. It offers standard and radiation sources for medical and industrial sectors; medical imaging and spect diagnostics, industrial analytical and instrument, high activity CS-137 and CO-60, and oil well logging sources; blood irradiators and environmental disposal source services; and bulk isotopes as well as calibration-related sources for radioisotopes. In addition, the company offers Tc-99m generators and supplies, trade in raw isotopes and other products, and services. It serves medical, scientific, and industrial applications. The company was formerly known as Eckert & Ziegler Strahlen- und Medizintechnik AG and changed its name to Eckert & Ziegler SE in March 2024. Eckert & Ziegler SE was founded in 1992 and is headquartered in Berlin, Germany.
Delcath Systems, Inc. is an interventional oncology firm operating in the United States and Europe, dedicated to developing treatments for both primary and secondary liver cancers. Its leading investigational product is the HEPZATO KIT, a unique hepatic delivery system for melphalan that targets high-dose chemotherapy specifically to the liver. This innovative approach aims to substantially reduce systemic drug exposure and mitigate associated side effects. HEPZATO's clinical evaluation is advancing through the FOCUS trial, which is designed to assess the objective response rate in individuals with metastatic uveal melanoma whose disease is primarily concentrated in the liver. Furthermore, the company offers a separate version of HEPZATO as a medical device in Europe, marketed under the CHEMOSAT Hepatic Delivery System brand (or simply CHEMOSAT). This system empowers European medical centers to manage a diverse array of liver cancer conditions. Delcath Systems, Inc. was established in 1988, with its corporate headquarters situated in New York, New York.
Sirtex Medical is a global healthcare company founded in 1997 with its U.S. headquarters in Woburn, Massachusetts. The company specializes in improving patient outcomes, offering products such as SIR-Spheres yttrium-90 microspheres, and maintains offices across the U.S., Australia, Germany, and Singapore.
Neshima Medical is a private medical device and therapeutics company headquartered in Dimona, Israel. The company develops innovative technologies designed to transform respiratory medicine by improving targeted drug delivery to the lungs.
Snipe Medical is a privately held medtech startup founded in 2021 and headquartered in Tel Aviv, Israel. The company develops therapeutic devices, specifically focusing on precision-targeted ablation solutions and novel treatments for lung cancer and solid tumors.
Get Alpha Tau Medical's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Alpha Tau Medical in Xcout Intel
- 16 named people with titles, LinkedIn and board committees
- 1 funding round before the IPO with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access